Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Reactions Weekly
Metadata
Title
Sulprostone
Uterine rupture: case report
Publication date
01-09-2004
Publisher
Springer International Publishing
Published in
Reactions Weekly / Issue 1/2004
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI
https://doi.org/10.2165/00128415-200410190-00042

Other articles of this Issue 1/2004

Reactions Weekly 1/2004 Go to the issue

Incidence study

Rofecoxib, not celecoxib, associated with risk of new-onset hypertension

Case report

Ceftriaxone

Case report

Cotrimoxazole/tenoxicam

Case report

Methotrexate

Case report

Dextromethorphan

Clinical study

Fenofibrate plus rosiglitazone lowers HDL-cholesterol levels